Metoclopramide hydrochloride NEW

‌Metoclopramide HCl‌
‌⚙️ D2/5-HT3 Antagonist | 💊 Antiemetic for GERD & Gastroparesis | 🌟 >99% Purity‌

‌Overview‌

Metoclopramide HCl is a dual-action antagonist targeting ‌dopamine D2‌ and ‌serotonin 5-HT3 receptors‌, accelerating gastric motility and alleviating nausea/vomiting in ‌GERD‌ and ‌gastroparesis‌‌12. With >99% purity, it meets pharmaceutical-grade standards for clinical use‌23.

‌Key Features‌

• ‌⚡ Rapid Relief‌

  : Symptomatic improvement within ‌30–60 minutes‌.

• ‌🎯 Dual Mechanism‌

  : Blocks both D2 (gastric motility) and 5-HT3 (antiemetic) pathways‌16.

• ‌🧪 High Compatibility‌

  : Adaptable for oral tablets, IV injections, and IM formulations‌2.

‌Applications‌

• ‌GERD‌

  : Reduces acid reflux and esophageal damage‌16.

• ‌Diabetic Gastroparesis‌

  : Enhances delayed gastric emptying‌6.

• ‌Chemotherapy Support‌

  : FDA-approved for oncology-related nausea‌2.

‌Quality Assurance‌

• Complies with ‌USP/EP‌ standards‌.

• ‌HPLC-verified purity (>99%)‌ and ‌GC/MS-tested solvents‌.

‌Market Insight‌

Global GI drug demand grows at ‌6.2% CAGR (2025–2030)‌‌5, driven by rising GERD cases (~20% adults in developed regions)‌1. Metoclopramide remains a cost-effective frontline therapy‌25.

‌Keywords‌: D2 antagonist, 5-HT3 blocker, antiemetic drug, GERD treatment, high-purity API

Citations: ‌12 | Updated: Feb 2025